Back to search Find a Tender

AWARD Complete

BH_NonClinical_Pharmacy_Car-T

Published 26 Nov 2025

26 Nov 2025

Barts Health NHS Trust

Primary CPV: 33000000 *
Medical equipments, pharmaceuticals and personal care products
Location: 🇬🇧 Tower Hamlets, London
Value: £2,100,000
Contract: 5 years Duration
08/12/2025 05/12/2030
Contract Types: 33 *Medical equipment, pharmaceuticals & per...
Full CPV Breakdown
SME suitable: Not stated

Publisher Address

20 Churchill Place, Canary Wharf, London, E14 5HJ, United Kingdom · UKI42

Contact

ol••••• Upgrade to Pro to see

Award Criteria

Not specified

FULL DOCUMENTATION

Related tenders

Barts Health NHS Trust

All notices from this publisher

Same CPV code

33000000 *

All notices with this CPV code

Reference: C402343

CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.

Awarded to

Bristol Myers Squibb £2,100,000

Full CPV breakdown

33000000 — Medical equipments, pharmaceuticals and personal care products (primary)

Notice details

Buyer type: Central government
Competition: Direct award (no competition)
Contract type: Services
Winning supplier: Large company
Procurement method: Direct award
Main category: Services
Above threshold: Yes
Legal basis: UKPGA 2023/54
Notice status: Complete
Award status: Pending
Contract can be extended to: 7 Dec 2035
Renewal: Option to extend contract by a further 5 years
Language: EN
Published: 26 Nov 2025 09:46
OCID: ocds-h6vhtk-05e8d3
Notice ID: C402343

Organisations on this notice

Bristol Myers Squibb

Supplier Large

Arc Uxbridge Sanderson Road, New Denham,, Denham, UB8 1DH, United Kingdom

jo••••• Upgrade to Pro to see

GB-COH 02487574

Key dates

Future Signature Date: 8 Dec 2025 · Scheduled

Full notice record

54 details

Everything the publisher included in this notice, organised by section. Contact details hidden: upgrade to Pro to see

Organisations

Party 1 › Name	Barts Health NHS Trust
Party 1 › Address › Street	20 Churchill Place, Canary Wharf
Party 1 › Address › Town / city	London
Party 1 › Address › Postcode	E14 5HJ
Party 1 › Address › Country	GB
Party 1 › Address › Country	United Kingdom
Party 1 › Address › Region (NUTS)	UKI42
Party 1 › Role	buyer
Party 1 › Link	https://www.bartshealth.nhs.uk
Party 1 › Classification › Description	Public authority - central government
Party 2 › Name	Bristol Myers Squibb
Party 2 › Address › Street	Arc Uxbridge Sanderson Road, New Denham,
Party 2 › Address › Town / city	Denham
Party 2 › Address › Postcode	UB8 1DH
Party 2 › Address › Country	GB
Party 2 › Address › Country	United Kingdom
Party 2 › Address › Region (NUTS)	UKJ13
Party 2 › Role	supplier
Party 2 › Business size	large
Party 2 › VCSEs	No

Buyer

Name	Barts Health NHS Trust

Tender

Title	BH_NonClinical_Pharmacy_Car-T
Description	CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.
Status	complete
Procedure type	direct
Procedure	Direct award
Reason for this procedure	CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells. The products can only be supplied by the the proposed contractor, Bristol Myers Squibb.
Lot › Status	complete
Document › Document type	Conflict of interest
Document › Description	Not published

Awards

Title	Provision of CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) products
Status	pending
Value › Value incl. VAT	£2,520,000
Value › Value	£2,100,000
Value › Currency	GBP
Category	services
Above threshold	Yes
Supplier › Name	Bristol Myers Squibb
Item › CPV › CPV 1 › Description	Medical equipments, pharmaceuticals and personal care products
Item › CPV › CPV 2 › Description	Pharmacy services
Contract period › Start	8 Dec 2025
Contract period › End	5 Dec 2030
Contract period › Can be extended to	7 Dec 2035
Can be renewed	Yes
Renewal › Description	Option to extend contract by a further 5 years
Has options	Yes
Options › Description	Extension option
Document › Document type	Award notice
Document › Description	Transparency notice on Find a Tender
Document › Link	https://www.find-tender.service.gov.uk/Notice/077086-2025
Document › Published	26 Nov 2025
Milestone › Type	Future signature date
Milestone › Due	8 Dec 2025
Milestone › Status	scheduled

Track this tender

Track this tender in your bid pipeline and set reminders.

See plans